本次股东大会采取现场表决和网络投票相结合的表决方式。本次股东大会现 场会议于 2025 年 8 月 25 日 14:30 在天津市自贸试验区（空港经济区）东九道 1 号公司会议室如期举行。网络投票时间为：（1）通过深圳证券交易所交易系统 进行网络投票的具体时间为：2025 年 8 月 25 日 9:15-9:25，9:30-11:30 和 13:00-15:00；（2）通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 8 月 25 日 9:15-15:00 期间的任意时间。 中国北京建国门外大街 1 号国贸写字楼 2 座 12-15 层 100004 12-15th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于瑞普生物股份有限公司 2025 年第 ...

Market Overview - On August 25, the animal health sector rose by 1.47%, led by Shenlian Biological, while the Shanghai Composite Index closed at 3883.56, up 1.51%, and the Shenzhen Component Index closed at 12441.07, up 2.26% [1]. Stock Performance - Shenlian Biological (688088) closed at 14.50, with a significant increase of 13.81% and a trading volume of 521,000 shares, amounting to 723 million yuan [1]. - Other notable stocks included: - KQ Biological (688526) at 18.10, up 2.67% [1]. - Dayu Biological (871970) at 10.25, up 1.18% [1]. - Huisheng Biological (300871) at 23.75, up 0.93% [1]. - Ruip Biological (300119) at 23.48, up 0.86% [1]. - Jinhai Biological (002688) at 7.31, up 0.55% [1]. Capital Flow - The animal health sector experienced a net outflow of 40.13 million yuan from institutional investors, while retail investors saw a net outflow of 60.97 million yuan. Conversely, speculative funds had a net inflow of 101 million yuan [2]. Individual Stock Capital Flow - Shenlian Biological had a net inflow of 35.39 million yuan from institutional investors, while retail investors faced a net outflow of 74.83 million yuan [3]. - Other stocks with notable capital flows included: - Pulaike (603566) with a net inflow of 3.28 million yuan from institutional investors and a net outflow of 9.68 million yuan from retail investors [3]. - Huisheng Biological (300871) had a net inflow of 2.55 million yuan from institutional investors but a net outflow of 13.77 million yuan from retail investors [3].

Investment Rating - The report maintains a "Buy" rating for the agriculture, forestry, animal husbandry, and fishery sector [4] Core Viewpoints - The report indicates that the destocking phase for live pigs is nearing its end, with a focus on the effects of a new round of pork reserves [1] - The report highlights a recent decline in pork prices, with the average price for live pigs at 13.75 yuan/kg, down 0.07% week-on-week, and a significant drop in the price of piglets by 3.78% to 27.78 yuan/kg [1][22] - The report notes an increase in the average weight of slaughtered pigs, which is expected to stabilize prices as the government resumes pork reserves to boost market sentiment [1][22] Summary by Sections 1. Market Overview - The agriculture, forestry, animal husbandry, and fishery sector underperformed compared to the broader market, with the sector index rising by 3.72% while the Shanghai Composite Index rose by 3.49% [13] - The report provides a detailed performance breakdown of sub-sectors, with livestock farming showing a 4.31% increase [13] 2. Key Data Tracking 2.1 Live Pigs - The average weight of slaughtered pigs is reported at 127.98 kg, showing a slight increase of 0.16 kg week-on-week [22] - The national frozen meat storage capacity rate is at 14.77%, up 0.1 percentage points [22] 2.2 White Feather Broilers - The price of white feather broilers increased to 7.33 yuan/kg, up 1.81% week-on-week, while chick prices remained stable at 3.58 yuan each [31] 2.3 Yellow Feather Broilers - The price of medium-speed chickens rose to 6.34 yuan/jin, reflecting a 4.97% increase, driven by rising demand post-typhoon [40] 2.4 Feed Sector - The report notes a decline in the prices of corn, wheat, and soybean meal, with corn averaging 2373.53 yuan/ton, down 0.86% week-on-week [2][45] 2.5 Major Agricultural Products - The price of natural rubber fell to 15640 yuan/ton, down 0.89% week-on-week, with inventory levels decreasing slightly [60] 3. Investment Recommendations - The report recommends focusing on the pig farming sector, suggesting that the long-term profitability cycle is beginning to improve, with specific companies highlighted for investment: Muyuan Foods, Wens Foodstuff Group, Juxing Agriculture, and Shennong Group [3] - It also suggests monitoring the feed and animal health sectors, particularly companies like Haida Group and Ruipu Biological, as demand is expected to rise [3] - In the planting chain, the report identifies investment opportunities in companies such as Suqian Agricultural Development and Beidahuang Group due to favorable grain price trends [3]

Group 1 - The core stock price of Reap Bio as of August 22, 2025, is 23.28 yuan, down 0.51% from the previous trading day, with a trading volume of 96,700 hands and a transaction amount of 224 million yuan [1] - Reap Bio's main business includes veterinary medicine and pet healthcare, with product lines such as animal vaccines, chemical drugs, and feed additives, and the company is actively expanding into the pet healthcare market [1] - The company forecasts a net profit attributable to shareholders for the first half of 2025 to be between 244 million yuan and 277 million yuan, representing a year-on-year growth of 50% to 70%, driven by rapid expansion in the pet healthcare sector and overseas market development [1] Group 2 - On the funding flow side, Reap Bio experienced a net outflow of 12.61 million yuan in main funds on the day, while there was a net inflow of 1.25 million yuan in the past five days [1]

Group 1 - The animal vaccine sector experienced a decline of 0.72% as of the market close on August 22, ranking among the top declines in concept sectors [1] - Within the animal vaccine sector, companies such as Shenlian Biological, Weilan Biological, and Xianfeng Holdings saw significant declines, while Kexing Pharmaceutical, Haizheng Pharmaceutical, and Guoyao Modern recorded increases of 2.06%, 0.44%, and 0.09% respectively [1] - The overall market saw a net outflow of 0.68 billion yuan from the animal vaccine sector, with 11 stocks experiencing net outflows, and 6 stocks seeing outflows exceeding 10 million yuan [2] Group 2 - The top net outflow in the animal vaccine sector was from Kanghua Biological, with a net outflow of 30.50 million yuan, followed by Shenlian Biological, Dabeinong, and Jinhai Biological with outflows of 27.38 million yuan, 24.27 million yuan, and 23.53 million yuan respectively [2] - Conversely, the stocks with the highest net inflows included Haizheng Pharmaceutical, Kexing Pharmaceutical, and Luoniushan, with net inflows of 27.34 million yuan, 16.70 million yuan, and 10.38 million yuan respectively [3] - The trading activity in the animal vaccine sector showed that Kanghua Biological had a turnover rate of 3.52% and a decline of 1.70%, while Kexing Pharmaceutical had a turnover rate of 3.12% and an increase of 2.06% [3]

Market Overview - The animal health sector experienced a decline of 0.76% on August 22, with Yongshun Biological leading the drop [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Individual Stock Performance - Yongshun Biological (code: 839729) closed at 11.18, down 4.36% with a trading volume of 91,600 shares and a turnover of 102 million yuan [1] - Dayu Biological (code: 871970) closed at 10.13, down 2.78% with a trading volume of 32,700 shares and a turnover of 33.49 million yuan [1] - Shunlian Biological (code: 688098) closed at 12.74, down 2.00% with a trading volume of 317,600 shares and a turnover of 412 million yuan [1] - Other notable declines include Xianfeng Holdings (code: 002141) down 1.79% and Jinhai Biological (code: 002688) down 1.36% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 74.19 million yuan from institutional investors, while retail investors had a net inflow of 91.60 million yuan [1] - Key stocks with significant capital flow include: - Huisheng Biological (code: 300871) with a net outflow of 9.62 million yuan from institutional investors [2] - Kexin Biological (code: 688526) with a net inflow of 7.28 million yuan from institutional investors [2] - ST Lvkang (code: 002868) had a net outflow of 3.99 million yuan from institutional investors but a net inflow of 3.77 million yuan from retail investors [2]

Company Overview - Reap Bio is located in Tianjin Free Trade Zone and was established on August 2, 2001, with its listing date on September 17, 2010 [1] - The company specializes in veterinary biological products (animal vaccines) and chemical pharmaceuticals [1] Stock Performance - As of August 22, Reap Bio's stock price decreased by 2.01%, trading at 22.93 CNY per share, with a total market capitalization of 10.657 billion CNY [1] - Year-to-date, the stock price has increased by 26.85%, with a 0.66% rise over the last five trading days, a 4.61% increase over the last 20 days, and a 7.02% decline over the last 60 days [1] Financial Performance - For the period from January to March 2025, Reap Bio reported a revenue of 822 million CNY, representing a year-on-year growth of 54.09% [2] - The company has distributed a total of 1.371 billion CNY in dividends since its A-share listing, with 462 million CNY distributed over the last three years [2] Shareholder Information - As of August 8, the number of shareholders for Reap Bio was 27,000, with an average of 12,406 circulating shares per shareholder [2] - As of March 31, 2025, the fifth largest circulating shareholder is Harvest Agricultural Industry Stock A, holding 6.3889 million shares, an increase of 696,900 shares from the previous period [2] Market Activity - On August 22, the net outflow of main funds was 7.9021 million CNY, with large orders accounting for 15.94% of purchases and 21% of sales [1]

在上海新国际博览中心的E1展馆内，优克联展台的演示屏幕上，一只柯基犬在做出高频习惯动作后， 随即触发项圈上的智能设备，与异地出差的宠物主开始了远程语音"通话"。这不是科幻电影场景，而是 第27届亚洲宠物展览会上的真实一幕。 8月21日上午9时，中国证券报记者在展馆外看到，观众已排起长龙。2600多家展商、31万平方米展览面 积、预计超过51万的参观人次……这些数字背后，是一个正在高速发展的"它经济"市场，而智能化是支 撑其高质量扩容的重要引擎。 "通过训练宠物做出特定动作，例如连续跳跃等，这款智能设备就能识别指令并向主人发起通话。"优克 联展台相关工作人员告诉记者，这款智能设备完全打破了传统定位器的功能边界，实现了本质突破，可 以构建起人宠双向实时通话的全新交互维度。 "依托宠物端可穿戴智能硬件与主人端App的协同架构，从户外精准寻宠、远程互动安抚，到健康数据 预警、日常趣味沟通，其全场景覆盖能力重新定义了宠物智能设备的价值维度。这种以情感交互为核心 的智能硬件模式，有望改写行业对'宠物科技'的认知边界。"上述工作人员表示。 随着养宠人群逐渐年轻化，宠物经济正从"喂饱就行"的基础需求，过渡到"精致养宠"的情感 ...

Core Insights - The pet economy is rapidly evolving, driven by technological advancements and a shift towards more sophisticated pet care practices [1][2][8] - The demand for smart pet products is increasing, with innovations such as AI-enabled devices and health monitoring systems gaining traction [2][3][8] - The supply chain for pet products is undergoing significant upgrades, enhancing efficiency and product quality [3][4][5][6] Industry Trends - The "it economy" is characterized by a growing emphasis on emotional consumption and refined pet care, moving beyond basic needs [2][8] - The integration of AI in pet products is becoming a key trend, with companies developing smart devices that enhance interaction between pets and owners [8] - The number of pet-related enterprises in China has surged, indicating a robust growth trajectory in the pet industry [7][8] Company Performance - Companies like Zhongchong Co. reported a 24.32% increase in revenue for the first half of 2025, reflecting the booming pet market [6] - Ruipubio expects a profit increase of 50% to 70% for the same period, driven by a focus on pet healthcare and supply chain integration [7] - New entrants, such as Yongli Co., are diversifying into the pet sector, highlighting the industry's attractiveness to various businesses [7] Technological Innovations - The Asia Pet Expo showcased cutting-edge products, including the world's first pet smartphone and automated pet care devices [1][2][3] - Companies are leveraging AI and big data to enhance production processes and product offerings in the pet food sector [3][4] - Innovations in packaging and logistics are crucial for meeting the seasonal demands and shelf-life challenges of pet food products [5][6]

证券之星消息，8月20日动物保健板块较上一交易日上涨0.27%，贤丰控股领涨。当日上证指数报收于 3766.21，上涨1.04%。深证成指报收于11926.74，上涨0.89%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002141 | 后丰控股 | 4.66 | 9.91% | 128.85万 | | 5.73亿 | | 688526 | 科前生物 | 17.75 | 1.02% | 3.69万 | | 6491.03万 | | 838275 | 驱动力 | 10.24 | 0.69% | 2.68万 | | 2725.11万 | | 603566 | 普莱柯 | 15.30 | 0.39% | 5.28万 | | 8055.89万 | | 600195 | 中牧股份 | 7.70 | 0.39% | 10.24万 | | 7851.28万 | | 871970 | 大禹生物 | 10.27 | 0.39% | 3.79万 | | 3888. ...